34025-17-7 Usage
Application
Used in pharmaceutical research
Potential as an Anti-cancer Agent
Mechanism: Inhibits the growth of cancer cells
Research Focus: Investigated for its anti-cancer properties
Potential Treatment of Neurodegenerative Diseases
Research Interest: Investigated for its neuroprotective effects
Anti-inflammatory and Analgesic Properties
Pharmacological Effects: Exhibits anti-inflammatory and analgesic properties
Antioxidant Activity
Potential: Shows potential as a compound with antioxidant activity
Research Status
Current Understanding: Limited, further research required to fully comprehend therapeutic applications
Check Digit Verification of cas no
The CAS Registry Mumber 34025-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,0,2 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 34025-17:
(7*3)+(6*4)+(5*0)+(4*2)+(3*5)+(2*1)+(1*7)=77
77 % 10 = 7
So 34025-17-7 is a valid CAS Registry Number.
34025-17-7Relevant academic research and scientific papers
Hydrazinium Salts as Novel Thermally Latent Broensted Acid-Inducing Initiators
Lee, Sang-Bong,Park, Young-Suk,Lee, Kyu-Wan,Endo, Takeshi
, p. 287 - 288 (2007/10/02)
1,2-Substituted-1,1-dimethylhydrazinium hexafluoroantimonates and their derivatives, R2(Me)2N+NHC(O)R1 SbF6- (2) served as thermally latent cationic initiators in the bulk polymerization of glycidyl phenyl ether
